NDC 10157-9535

Blistex Daily Conditioning Treatment

Petrolatum, Octinoxate, And Oxybenzone

Blistex Daily Conditioning Treatment is a Topical Paste in the Human Otc Drug category. It is labeled and distributed by Blistex Inc.. The primary component is Petrolatum; Octinoxate; Oxybenzone.

• Product ID: 10157-9535_5be791fc-5bae-46e8-a7d4-99e84de3a087
• NDC: 10157-9535
• Product Type: Human Otc Drug
• Proprietary Name: Blistex Daily Conditioning Treatment
• Generic Name: Petrolatum, Octinoxate, And Oxybenzone
• Dosage Form: Paste
• Route of Administration: TOPICAL
• Marketing Start Date: 2014-02-14
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part347
• Labeler Name: Blistex Inc.
• Substance Name: PETROLATUM; OCTINOXATE; OXYBENZONE
• Active Ingredient Strength: 55 g/100g; g/100g; g/100g
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 10157-9535-2

1 JAR in 1 BLISTER PACK (10157-9535-2) > 7 g in 1 JAR

• Marketing Start Date: 2014-02-14
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 10157-9535-2 [10157953502]

Blistex Daily Conditioning Treatment PASTE

• Marketing Category: OTC MONOGRAPH FINAL
• Application Number: part347
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2014-02-14
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
PETROLATUM	54.86 g/100g

OpenFDA Data

• SPL SET ID: e60d6a7d-6262-4119-a68b-680bb77b5929
• Manufacturer:
  • Blistex Inc.
• UNII:
  • 95OOS7VE0Y
  • 4Y5P7MUD51
  • 4T6H12BN9U
• UPC Code:
  • 0041388260013